BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023

  Fulcrum Therapeutics, Inc.® reported financial results for the third quarter of 2023 and provided a business update.

  November 7, 2023

   · 

  11 min read
• Business

  Harvard Bioscience Announces Third Quarter 2023 Financial Results

  Overall, I’m encouraged to see solid year-over-year third quarter revenue growth in North America in a quarter that had significant headwinds in Asia.

  November 7, 2023

   · 

  13 min read
• Genetown

  Tango Therapeutics to Present at the Jefferies 2023 London Healthcare Conference

  Tango Therapeutics, Inc. announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 1:00 PM GMT.

  November 7, 2023

   · 

  1 min read
• Business

  Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14

  Renalytix plc announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open.

  November 7, 2023

   · 

  1 min read
• Business

  Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023

  Predictive Oncology Inc. announced that it will report its financial results for the third quarter ended September 30th, 2023 before the markets open on Tuesday, November 14, 2023.

  November 7, 2023

   · 

  2 min read
• Business

  908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

  908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, reported financial results for the quarter ended September 30, 2023.

  November 7, 2023

   · 

  7 min read
• Business

  Novanta Announces Financial Results for the Third Quarter 2023

  Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the third quarter 2023.

  November 7, 2023

   · 

  29 min read
• Biotech Beach

  Glaukos Announces Participation in Stifel Healthcare Conference

  Glaukos Corporation announced that its management is scheduled to participate in the Stifel Healthcare Conference on Tuesday, November 14, 2023, at 10:55 a.m. ET in New York City.

  November 7, 2023

   · 

  1 min read
• Pharm Country

  Arbutus Announces CEO, William Collier, to Retire December 31, 2023

  Arbutus Biopharma Corporation announced that William Collier will retire from his position as the Company’s President and Chief Executive Officer, and as a member of the Board of Directors, at the end of 2023.

  November 7, 2023

   · 

  7 min read
• Business

  Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

  Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results and corporate updates for the third quarter ended September 30, 2023.

  November 7, 2023

   · 

  15 min read